December 27, 2014 5:32 AM ET

Healthcare Equipment and Supplies

Company Overview of AqueSys, Inc.

Company Overview

AqueSys, Inc., an ophthalmic company, focuses on innovating and commercializing implantable devices that improves the treatment of glaucoma. It offers XEN, a gel stent that creates a diffuse outflow of aqueous from the anterior chamber into the non-dissected tissue of the subconjunctival space. The company’s XEN gel stent creates a new pathway to allow the excess fluid in eyes to flow out, and lowers the eye pressure. AqueSys, Inc. was incorporated in 2005 and is based in Aliso Viejo, California.

26970 Aliso Viejo Parkway

Suite 200

Aliso Viejo, CA 92656

United States

Founded in 2005





Key Executives for AqueSys, Inc.

Chief Executive Officer
Board Observer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
EiRx Pharmaceutical Limited United States
CoAxia, Inc. United States
Regenesis Biomedical, Inc. United States
Cramer Products Inc. United States
Apira Science, Inc. United States

Recent Private Companies Transactions

Private Placement
January 15, 2014

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AqueSys, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at